GlassScriptPhysician profile
Kathryn Reise
NPI 1093177156
$4,925.62
in general payments reported to CMS, 2019-2025
34 companies · $643 in 2025
The $643 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $447 · 2021: $571 · 2022: $869 · 2023: $979 · 2024: $1,205 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,826.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $787.76 | 2020-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Abbvie INC. | $743.89 | 2019-2025 | |
| Organon LLC | $452.43 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $392.91 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $370.85 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $203.52 | 2020-2025 | Slynd |
| Medtronic, INC. | $168.17 | 2024-2025 | Truclear |
| Bayer Healthcare Pharmaceuticals INC. | $166.93 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $160.42 | 2022-2025 | |
| Gynesonics, INC. | $124.99 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medical Device Business Services, INC. | $117.93 | 2021 | |
| Minerva Surgical, INC | $107.15 | 2021-2023 | |
| Daiichi Sankyo INC. | $106.47 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $106.32 | 2019 | |
| Roche Diagnostics Corporation | $106.08 | 2023 | Cobas 4800 Ct/Ng Test V2.0 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $105.44 | 2023 | Apretude |
| Intuitive Surgical, INC. | $99.37 | 2023 | |
| Baxter Healthcare | $69.06 | 2024-2025 | Perclot |
| Optumhealth Care Solutions, LLC | $65.11 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Therapeuticsmd, INC. | $61.88 | 2020-2021 | |
| Avion Pharmaceuticals | $60.37 | 2020-2022 | |
| Biogen, INC. | $49.55 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $44.77 | 2024 | Ova1 |
| Pfizer INC. | $37.56 | 2024-2025 | |
| Momentis Surgical INC. | $34.00 | 2022 | |
| Millicent US INC | $33.32 | 2023-2024 | Femring, Intrarosa |
| Agile Therapeutics, INC. | $31.65 | 2021-2023 | Twirla |
| Boston Scientific Corporation | $21.21 | 2025 | General - Vascular Intervention |
| Amgen INC. | $20.00 | 2022 | |
| Medicem INC. | $18.43 | 2023 | |
| Becton, Dickinson and Company | $15.94 | 2024 | Bd Onclarity |
| Avanos Medical | $14.91 | 2021 | |
| Merck Sharp & Dohme LLC | $13.97 | 2020 | |
| Lupin INC. | $13.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Reise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.